Growth Metrics

NovoCure (NVCR) Change in Account Payables (2016 - 2019)

NovoCure's Change in Account Payables history spans 6 years, with the latest figure at $126000.0 for Q2 2019.

  • On a quarterly basis, Change in Account Payables fell 87.6% to $126000.0 in Q2 2019 year-over-year; TTM through Jun 2019 was $9.6 million, a 32.44% increase, with the full-year FY2018 number at $9.5 million, up 926.35% from a year prior.
  • Change in Account Payables hit $126000.0 in Q2 2019 for NovoCure, down from $3.2 million in the prior quarter.
  • Over the last five years, Change in Account Payables for NVCR hit a ceiling of $6.7 million in Q4 2018 and a floor of -$6.8 million in Q3 2016.
  • Historically, Change in Account Payables has averaged $1.1 million across 5 years, with a median of $1.7 million in 2015.
  • The widest YoY moves for Change in Account Payables: up 371.28% in 2016, down 547.42% in 2016.
  • Tracing NVCR's Change in Account Payables over 5 years: stood at $2.4 million in 2015, then soared by 78.6% to $4.2 million in 2016, then decreased by 27.45% to $3.1 million in 2017, then surged by 117.27% to $6.7 million in 2018, then tumbled by 98.11% to $126000.0 in 2019.
  • Business Quant data shows Change in Account Payables for NVCR at $126000.0 in Q2 2019, $3.2 million in Q1 2019, and $6.7 million in Q4 2018.